Unravelling the puzzle of immunotherapeutic efficacy in lung cancer No … ← A rare case report of a primary lung cancer comprising adenocarcinoma and atypical carcinoid tumor, with the carcinoid component harboring <em>EML4-ALK</em> rearrangement Myeloid-derived suppressor cells in peripheral blood as predictive biomarkers in patients with solid tumors undergoing immune checkpoint therapy: systematic review and meta-analysis →